Beovu is a prescription medication that is used to treat wet age-related macular degeneration (AMD). This condition is a leading cause of vision loss in older adults and occurs when abnormal blood vessels grow and leak fluid into the macula, the central part of the retina responsible for sharp, central vision.

Beovu works by targeting a protein called vascular endothelial growth factor (VEGF), which plays a key role in the growth of abnormal blood vessels in the eye. By blocking VEGF, Beovu helps to reduce the growth and leakage of these blood vessels, ultimately preserving and improving vision in patients with wet AMD.

It is important to follow your healthcare provider’s instructions when taking Beovu, as it is typically administered as an injection into the eye. Your healthcare provider will determine the appropriate dosage and frequency of injections based on your individual needs and response to treatment.

As with any medication, Beovu may cause side effects in some patients. Common side effects may include eye pain, blurred vision, and increased sensitivity to light. It is important to report any unusual or severe side effects to your healthcare provider promptly.

Overall, Beovu has been shown to be an effective treatment for wet AMD and has helped many patients preserve and improve their vision. If you have been diagnosed with wet AMD, talk to your healthcare provider about whether Beovu may be a suitable treatment option for you.